Skip to main content
. 2022 Mar 24;12:5076. doi: 10.1038/s41598-022-09078-z

Figure 8.

Figure 8

AXLi limits autophagic flux at a late stage in the autophagy pathway. Melmet 1 cells were treated with 1 µM AXLi for 48 h with or without co-treatment with 100 nM lysosomal inhibitor Bafilomycin A1 (Baf) for the 3 final hours of the treatment (DMSO for control). As a positive control, cells were in addition to Baf subjected to amino acid starvation by incubation in EBSS medium for 3 h. (a) Expression levels of indicated proteins in the differently treated cells. A representative western image is shown (cropped gel). Quantified expression levels of LC3B-II (after normalization to the loading control, β-actin) presented as relative to non-treated control set to 1. Average ± St. Dev, n = 2. (b) The LDH sequestered assay was performed and the results presented as the mean LDH sequestration activities (in %/h) in differently treated cells, normalized to the control set to 0. Average ± SEM, n = 3, *p ≤ 0.05; **p ≤ 0.01.